PHOSPHATE SUSPENSIONS

Details for Australian Patent Application No. 2002328885 (hide)

Owner HUNTSMAN INTERNATIONAL LLC

Inventors HAWKINS, John

Pub. Number AU-A-2002328885

PCT Number PCT/EP02/07786

PCT Pub. Number WO2003/010270

Priority 0117676.7 20.07.01 GB

Filing date 12 July 2002

Wipo publication date 17 February 2003

International Classifications

C11D 007/16 Compositions of detergents based essentially on non-surface-active compounds

C11D 007/26 Compositions of detergents based essentially on non-surface-active compounds

C11D 003/06 Other compounding ingredients of detergent compositions covered in group - Phosphates, including polyphosphates

C11D 003/22 Other compounding ingredients of detergent compositions covered in group - Carbohydrates or derivatives thereof

C11D 017/00 Detergent materials or soaps characterised by their shape or physical properties

Event Publications

30 January 2003 Complete Application Filed

  Priority application(s): 0117676.7 20.07.01 GB

29 May 2003 Application Open to Public Inspection

  Published as AU-A-2002328885

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002328886-INSERT FOR THE TREATMENT OF DRY EYE

2002328884-Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases